Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00147914 · ClinicalTrials.gov registry record · Phase 4
Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life
A Phase 4 study of Acute Bacterial Sinusitis, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00147914: Completed Phase 4 study of Acute Bacterial Sinusitis, sponsored by University of Chicago.
NCT00147914 is a Phase 4 study of Acute Bacterial Sinusitis that has completed, run by University of Chicago. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00147914, a Phase 4 study of Acute Bacterial Sinusitis, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a comparison between two commonly used antibiotics (Cefdinir vs. Amoxicillin/Clavulanate) in patients with acute sinus infection, surveying quality of life. The hypothesis is that the two treatments would be at the least equivalent based on clinical outcome measures of improvement in quality of life.
Conditions Studied
Interventions
- DRUG Cefdinir (drug)
- DRUG amoxicillin/clavulanate
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-02 |
| Est. Completion | 2017-02-18 |
| Phase | Phase 4 |
What the finished NCT00147914 record still lists
NCT00147914 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Acute Bacterial Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Cefdinir (drug) is the first listed.
NCT00147914 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00147914 about?
NCT00147914 is a clinical study titled "Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life". This study is a comparison between two commonly used antibiotics (Cefdinir vs. Amoxicillin/Clavulanate) in patients with acute sinus infection, surveying quality of life. The hypothesis is that the two treatments would be at the least equivalent based on clinical outcome measures of improvement in q...
What is the current status of trial NCT00147914?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2005-02. Estimated completion is 2017-02-18.
What conditions does trial NCT00147914 study?
This clinical trial studies the following conditions: Acute Bacterial Sinusitis.
What interventions are being tested in trial NCT00147914?
The interventions under investigation include: Cefdinir (drug) (DRUG), amoxicillin/clavulanate (DRUG).
Who is sponsoring clinical trial NCT00147914?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00147914 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00147914's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia